Figures & data
Table 1. Definitions of sepsis.
Figure 1. Sepsis may be divided into two phases. Following infection, a hyper-inflammatory phase is characterized by SIRS. This may resolve or the patient may progress to what is called severe sepsis. During this phase, there is evidence of CARS with immunosuppression and multiple organ dysfunction. This may also resolve, especially with appropriate support, but it often leads to death.
Figure 2. Sepsis begins with either infection or tissue injury. PAMPs from invading organisms or DAMPs from injured tissue cells (or both) are recognized by macrophage receptors such as the TLRs. This results in the production of pro-inflammatory cytokines such as TNF, IL-1β and IL-6 and chemokines such as IL-8 and MCP-1. IL-6 stimulates the liver to produce CRP and complement proteins. Many cells in the body also produce PCT in response to both infection and injury.
Figure 3. Activated inflammatory cells up-regulate a number of proteins which may be detected as biomarkers of sepsis, either on the cell surface or as soluble forms in plasma. (a) An unstimulated PMN; (b) a stimulated PMN with darker (“toxic”) granules and a Dohle body (arrow); (c) frequently utilized biomarkers of sepsis related to PMNs include CD64, the soluble forms of TREM-1 and CD11b, and HBP. (d) Frequently utilized biomarkers of sepsis related to macrophages or monocytes include the soluble forms of CD14 (which facilitates recognition of bacterial lipopolysaccharides) and the receptor for RAGE.
Figure 4. There is significant evidence that patients with severe sepsis have defective adaptive immunity. Macrophages (or monocytes) may lose expression of the Class II MHC proteins which display foreign peptide to the TCR. However, more importantly, T-cells upregulate expression of CTLA-4, an alternative ligand for the co-stimulator B7 on the antigen-presenting cell. Instead of providing co-stimulation and activation of the T-cell, which would occur if B7 interacted with CD28, interaction with CTLA-4 results in T-cell unresponsiveness and, eventually, death by apoptosis.
Figure 5. An alternative model for the progression of sepsis to severe sepsis proposes that the CARS begins while the pro-inflammatory SIRS is still present. Understanding the interplay of these opposing features may help investigators discover the pathogenesis of the organ dysfunction that occurs in patients who develop severe sepsis (and die).
